LPCN News and Press, Lipocine Inc. From 12/22/21

LIPOCINE ANNOUNCES PATIENT DOSED IN ITS PHASE 2 STUDY WITH LPCN 1148 FOR MANAGEMENT OF LIVER CIRRHOSIS PR Newswire SALT LAKE CITY , Dec. 22, 2021 /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic an...

Lipocine has obtained positive results in a phase 2 study using its drug LPCN1144 for the treatment of patients with NASH. TLANDO is being resubmitted to the FDA as a Class 1 resubmission with 2 months review time; possible FDA approval expected on January 28, 2022. It is estimate...

Lipocine Announces Financial Results for the Third Quarter Ended September 30, 2021 PR Newswire SALT LAKE CITY , Nov. 10, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorde...

5 Reddit Penny Stocks to Watch in November 2021 Finding penny stocks on Reddit is one of the most popular choices for investors to make. While not all penny stocks found on Reddit will be valuable, the discussion platform can be a great resource when creating a watchlist. One th...

The U.S. FDA has granted Fast Track Designation to Lipocine's (NASDAQ:LPCN) LPCN 1144 as a treatment for non-cirrhotic non-alcoholic steatohepatitis (NASH). Shares up more than 9% premarket. LPCN 1144 was recently studied in the Liver Fat intervention with oral Testosterone ((L...

Lipocine Announces FDA Grants Fast Track Designation to LPCN 1144 for Treatment of Non-Cirrhotic NASH PR Newswire SALT LAKE CITY , Nov. 4, 2021 /PRNewswire/ -- Lipocine Inc. (LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrin...

Lipocine Announces Multiple Poster Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021 Late Breaking Posters Will Feature Data From Phase 2 LiFT Study Investigating LPCN 1144 in NASH PR Newswire SALT LAKE C...

Energous (NASDAQ:WATT) +35% granted FCC approval for unlimited Distance over-the-air wireless charging Edesa Biotech (NASDAQ:EDSA) +29% reports favorable mortality reductions in COVID-19 study InflaRx (NASDAQ:IFRX) +21% after EUR 43.7M vilobelimab development grant En...

Penny Stocks Jump Early On Monday Call them penny stocks, small-cap stocks, cheap stocks, etc. However you identify them, the same result is apparent. For retail traders, capitalizing on quick moves in the stock market is the goal, and what penny stocks offer is one of the clear solutio...

ION Geophysical (NYSE:IO) +45% sees Q3 revenues more than doubling Q/Q Valneva SE (NASDAQ:VALN) +36% after topline results from late-stage VLA2001 COVID-19 trial Adamis Pharmaceuticals (NASDAQ:ADMP) +35% after FDA approves opioid overdose treatment ZIMHI MeiraGTx...